<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2006-4-531-538</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-485</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>АПОПТОЗ ЛИМФОЦИТОВ ПРИ ПСОРИАЗЕ</article-title><trans-title-group xml:lang="en"><trans-title>LYMPHOCYTE APOPTOSIS IN PSORIASIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Капулер</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kapuler</surname><given-names>О. M.</given-names></name></name-alternatives><email xlink:type="simple">srgsib@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нелюбин</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nelyubin</surname><given-names>Е. V.</given-names></name></name-alternatives><email xlink:type="simple">srgsib@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каут</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaut</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>лаборатория иммунофармакологии и иммунотоксикологии</p></bio><email xlink:type="simple">srgsib@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сибиряк</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sibiryak</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф., зав. лабораторией иммунофармакологии и иммунотоксикологии ИИФ УрО РАН</p><p>зав. отделом иммунологии ФГУ “Всероссийский центр глазной и пластической хирургии” Росздрава</p><p>450075, Уфа, ул. Р. Зорге 67/1, ФГУ ВЦГПХ Росздрава, отдел иммунологии, Тел.: 3472 - 329-942, 3472 - 517-193, М.т. 89173490499, 89019524623</p></bio><email xlink:type="simple">srgsib@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ОАО “Медицинская косметология” МЗ РБ, Уфа</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Институт иммунологии и физиологии УрО РАН, Екатеринбург – Уфа</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>22</day><month>07</month><year>2014</year></pub-date><volume>8</volume><issue>4</issue><fpage>531</fpage><lpage>538</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Капулер О.М., Нелюбин Е.В., Каут Д.А., Сибиряк С.В., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Капулер О.М., Нелюбин Е.В., Каут Д.А., Сибиряк С.В.</copyright-holder><copyright-holder xml:lang="en">Kapuler О.M., Nelyubin Е.V., Kaut D.A., Sibiryak S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/485">https://www.mimmun.ru/mimmun/article/view/485</self-uri><abstract><p>Резюме. Обследованы 42 пациента с прогрессирующим вульгарным псориазом (средняя величина PASI равна 19,7 ± 1,5) и 40 условно-здоровых доноров. Установлено, что у больных псориазом увеличено количество CD4+ CD95+ Т- лимфоцитов в периферической крови, содержание которых положительно коррелирует с величиной PASI, и повышен уровень растворимого Fas рецептора (sFas) в сыворотке (1868,1 ± 186,8 пкг/мл против 1281,4 ± 142,5 пкг/мл у здоровых доноров, PLSD = 0.019). Интенсивность спонтанного апоптоза лимфоцитов и апоптоза, индуцированного антиFas МКА у больных псориазом аналогичны таковым у здоровых доноров, однако чувствительность лимфоцитов к апоптозу, индуцированному “оксидативным стрессом” (50 мкМ Н202, 4 часа) значимо снижается. При параллельной оценке структуры клеточного цикла (метахроматическое окрашивание акридиновым оранжевым), интенсивности апоптоза и экспрессии Fas-рецептора (двухпараметрическое окрашивание AnnV-FITC/антиFas МКА-PE) после кратковременной стимуляции митогеном (PHA-P, 5 мкг/мл, 24 часа) выявлено, что лимфоциты здоровых лиц и больных псориазом существенно не отличаются по митотической активности, интенсивности активационного апоптоза и величине активационно-индуцированной экспрессии Fas-рецептора. В то же время, соотношение между содержанием AnnV+CD95+ лимфоцитов и суммарным содержанием AnnV+ ФГА-активированных лимфоцитов при псориазе значимо снижалось, что свидетельствует об уменьшение “доли” Fas-зависимых механизмов апоптоза при активации клеток. Полученные данные подтверждают точку зрения, что в патогенезе псориатического процесса, как и в развитии других аутоиммунных заболеваний, важная роль принадлежит нарушениям “апоптотической реактивности” лимфоцитов.</p></abstract><trans-abstract xml:lang="en"><p>Abstract. Forty-two patients with progressive vulgar psoriasis (PASI = 19.7 ± 1.5) and 40 healthy volunteers were under investigation. Psoriatic patients were characterized by increased number of CD4+ CD95+ peripheral blood T lymphocytes, which correlates with clinical psoriatic score, and by increased levels of soluble Fas (sFas) in serum, as compared to controls (resp., 1868.1 ± 186.8 pg/ml vs. 1281.4 ± 142.5 pg/ml, PLSD = 0.019). The levels of spontaneous lymphocyte apoptosis and anti-Fas (Mab)-induced apoptosis in psoriatic patients did not differ from the controls. However, apoptosis induced by “oxidative stress” (50 M Н202, 4 hrs) was depressed in the patients. Moreover, a simultaneous assessment of cell cycle structure (metachromatic staining with Acridine Orange), apoptosis and Fas receptor expression (AnnV-FITC/antiFas mAbs-PE staining) following a short-term mitogenic stimulation (PHA-P, 5 µg/ml, 24 hrs) were performed. We found no marked differences in mitogenic reactivity, activation-induced apoptosis, and activation-induced Fas receptor expression when studying lymphocytes from healthy donors and psoriatic patients. However, PHA-activated lymphocytes from psoriatic patients displayed a significantly decreased ratio of AnnV+CD95+ to the total AnnV+ subpopulation, thus suggesting a decreased role of Fas-dependent mechanisms of apoptosis during the cell activation. The data obtained confirm a view, that an abnormal lymphocyte “apoptotic reactivity”, which plays a crucial role in the mechanisms of autoimmunity, may also of importance in the pathogenesis of psoriasis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>спонтанный и индуцированный апоптоз лимфоцитов</kwd><kwd>растворимый Fas рецептор</kwd><kwd>псориаз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>spontaneous lymphocyte apoptosis</kwd><kwd>induced lymphocyte apoptosis</kwd><kwd>soluble Fas receptor</kwd><kwd>psoriasis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Казанцева И. А. Апоптоз и его роль в патологии кожи // Российский журнал кожных и венерических болезней - 2000. - №4. - С. 17-22.</mixed-citation><mixed-citation xml:lang="en">Казанцева И. А. Апоптоз и его роль в патологии кожи // Российский журнал кожных и венерических болезней - 2000. - №4. - С. 17-22.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Капулер О.М., Каут Д.А., Сибиряк С.В. Субпопуляционная структура лимфоцитов при псориазе // Иммунология Урала (Материалы IV конф. Иммунологов Урала). - 2005. - № 1(4) - С. 61-62.</mixed-citation><mixed-citation xml:lang="en">Капулер О.М., Каут Д.А., Сибиряк С.В. Субпопуляционная структура лимфоцитов при псориазе // Иммунология Урала (Материалы IV конф. Иммунологов Урала). - 2005. - № 1(4) - С. 61-62.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ковальчук Л.В., Чередеев А.Н. Новые иммунопатогенетические взгляды: апоптотические иммунодефициты // Иммунология. - 1998. - № 6. - С. 17-18.</mixed-citation><mixed-citation xml:lang="en">Ковальчук Л.В., Чередеев А.Н. Новые иммунопатогенетические взгляды: апоптотические иммунодефициты // Иммунология. - 1998. - № 6. - С. 17-18.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кунгуров Н.В., Филимонкова Н.Н., Тузанкина И.А. Псориатическая болезнь. - Екатеринбург: Изд-во Урал. Ун-та, 2002. - 200 с.</mixed-citation><mixed-citation xml:lang="en">Кунгуров Н.В., Филимонкова Н.Н., Тузанкина И.А. Псориатическая болезнь. - Екатеринбург: Изд-во Урал. Ун-та, 2002. - 200 с.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков А.И., Кононов А.В., Охлопков В.А., Правдина О.В. и др. Иммунохимические исследования при псориазе // Вестн. дерматол. венерол. - 2003. - № 3. - C. 26-28.</mixed-citation><mixed-citation xml:lang="en">Новиков А.И., Кононов А.В., Охлопков В.А., Правдина О.В. и др. Иммунохимические исследования при псориазе // Вестн. дерматол. венерол. - 2003. - № 3. - C. 26-28.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ярилин А.А. Апоптоз и его место в иммунных процессах // Иммунология. - 1996. - № 6. - С. 10 - 23.</mixed-citation><mixed-citation xml:lang="en">Ярилин А.А. Апоптоз и его место в иммунных процессах // Иммунология. - 1996. - № 6. - С. 10 - 23.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Arnold R., Seifert M., Asadullah Kh., Dieter H. et al. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand Interaction: Modulation by Cytokines processes // J. Immunol. - 1999. - Vol. 162. - P.7140 - 7147.</mixed-citation><mixed-citation xml:lang="en">Arnold R., Seifert M., Asadullah Kh., Dieter H. et al. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand Interaction: Modulation by Cytokines processes // J. Immunol. - 1999. - Vol. 162. - P.7140 - 7147.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Budd R. Death receptors couple both cell proliferation and apoptosis // J. Clin. Invest. - 2002. - Vol. 109. - P.437-450.</mixed-citation><mixed-citation xml:lang="en">Budd R. Death receptors couple both cell proliferation and apoptosis // J. Clin. Invest. - 2002. - Vol. 109. - P.437-450.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng J., Zhou T., Liu C., Shapiro J. et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule // Science - 1994. - Vol. 263. - P. 1759-1762.</mixed-citation><mixed-citation xml:lang="en">Cheng J., Zhou T., Liu C., Shapiro J. et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule // Science - 1994. - Vol. 263. - P. 1759-1762.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Christensson M., Pettersson E., Eneslatt K. et al. Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases // J. Clin Immunol. - 2002.- Vol. 22. - P. 220-227.</mixed-citation><mixed-citation xml:lang="en">Christensson M., Pettersson E., Eneslatt K. et al. Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases // J. Clin Immunol. - 2002.- Vol. 22. - P. 220-227.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Darzynkiewicz Z. Simultaneous analysis of cellular RNA and DNA content // Meth. Cell Biol. - 1994. - Vol. 41. - P. 401-420.</mixed-citation><mixed-citation xml:lang="en">Darzynkiewicz Z. Simultaneous analysis of cellular RNA and DNA content // Meth. Cell Biol. - 1994. - Vol. 41. - P. 401-420.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gladman D. Discussion: Clinical features, epidemiology, classification criteria, and quality of life in psoriasis and psoriatic arthritis // Ann. Rheum. Dis. - 2005. - Vol.64. - P.24-25.</mixed-citation><mixed-citation xml:lang="en">Gladman D. Discussion: Clinical features, epidemiology, classification criteria, and quality of life in psoriasis and psoriatic arthritis // Ann. Rheum. Dis. - 2005. - Vol.64. - P.24-25.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hildeman D., Mitchell Th., Kappler J., Marrack Ph. T cell apoptosis and reactive oxygen species // J. Clin. Invest. - 2003. - Vol. 111. - P. 575-581.</mixed-citation><mixed-citation xml:lang="en">Hildeman D., Mitchell Th., Kappler J., Marrack Ph. T cell apoptosis and reactive oxygen species // J. Clin. Invest. - 2003. - Vol. 111. - P. 575-581.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Knipping E., Krammer P., Onel K. et al. Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis // Arthritis Rheum. - 1995. - Vol. 38. - P. 1735-1737.</mixed-citation><mixed-citation xml:lang="en">Knipping E., Krammer P., Onel K. et al. Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis // Arthritis Rheum. - 1995. - Vol. 38. - P. 1735-1737.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Koopman G., Reuterlingsperger C., Kiijten G., Keehnen R. et al. Annexin V for flow cytometric detection of phosphatidylserine expression of B cells undergoing apoptosis // Blood. - 1994. - Vol. 84. - P. 1415 - 1420.</mixed-citation><mixed-citation xml:lang="en">Koopman G., Reuterlingsperger C., Kiijten G., Keehnen R. et al. Annexin V for flow cytometric detection of phosphatidylserine expression of B cells undergoing apoptosis // Blood. - 1994. - Vol. 84. - P. 1415 - 1420.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Krammer P. CD95’s deadly mission in the immune system // Nature. - 2000. - Vol. 407. - P. 789 - 795.</mixed-citation><mixed-citation xml:lang="en">Krammer P. CD95’s deadly mission in the immune system // Nature. - 2000. - Vol. 407. - P. 789 - 795.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lahdenpohja N., Naive H. (CD45RA+) T lymphocytes are more sensitive to oxidative stress-induced signals than memory (CD45RO+) cells // Cell Immunol. - 1996. - Vol. 173. - P. 282-286.</mixed-citation><mixed-citation xml:lang="en">Lahdenpohja N., Naive H. (CD45RA+) T lymphocytes are more sensitive to oxidative stress-induced signals than memory (CD45RO+) cells // Cell Immunol. - 1996. - Vol. 173. - P. 282-286.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lecewicz-Torun B., Pietrzak A., Rolinski J., Brzozowski W. The peripheral blood lymphocyte pattern in psoriasis proceeded by an infection // Med. Sci. Monit. - 2001. - Vol.7. - P. 889-893.</mixed-citation><mixed-citation xml:lang="en">Lecewicz-Torun B., Pietrzak A., Rolinski J., Brzozowski W. The peripheral blood lymphocyte pattern in psoriasis proceeded by an infection // Med. Sci. Monit. - 2001. - Vol.7. - P. 889-893.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lorenz H., Grunke M., Hieronymus T. et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases // Arthritis Rheum. - 1997 . - Vol. 40. - P. 306-317.</mixed-citation><mixed-citation xml:lang="en">Lorenz H., Grunke M., Hieronymus T. et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases // Arthritis Rheum. - 1997 . - Vol. 40. - P. 306-317.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Nickoloff B., Nestle O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities // J. Clin. Invest. - 2004. - Vol. 113. - P.1664-1675.</mixed-citation><mixed-citation xml:lang="en">Nickoloff B., Nestle O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities // J. Clin. Invest. - 2004. - Vol. 113. - P.1664-1675.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nozawa K., Kayagaki N., Tokano Y. Et al. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases // Arthritis Rheum. - 1997. - Vol. 40. - P. 1126-1129.</mixed-citation><mixed-citation xml:lang="en">Nozawa K., Kayagaki N., Tokano Y. Et al. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases // Arthritis Rheum. - 1997. - Vol. 40. - P. 1126-1129.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Papoff G., Cascino I., Eramo A. et al. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro // J. Immunol. - 1996. - Vol. 156. - P. 4622-4630.</mixed-citation><mixed-citation xml:lang="en">Papoff G., Cascino I., Eramo A. et al. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro // J. Immunol. - 1996. - Vol. 156. - P. 4622-4630.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Seishima M., Seishima M., Takemura M., Saito K. et al. Increased serum soluble Fas, tumor necrosis factor alpha and interleukin 6 concentrations in generalized pustular psoriasis // Dermatology.- 1998. - Vol. 196. - P.371-372.</mixed-citation><mixed-citation xml:lang="en">Seishima M., Seishima M., Takemura M., Saito K. et al. Increased serum soluble Fas, tumor necrosis factor alpha and interleukin 6 concentrations in generalized pustular psoriasis // Dermatology.- 1998. - Vol. 196. - P.371-372.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Linden M., T Van Lopik T., L A Aarden L. et al. Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives //Ann. Rheum. Dis. - Vol. 2001. - Vol. 60. - P. 237-241.</mixed-citation><mixed-citation xml:lang="en">Van der Linden M., T Van Lopik T., L A Aarden L. et al. Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives //Ann. Rheum. Dis. - Vol. 2001. - Vol. 60. - P. 237-241.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Vissers W., Arndtz C., Muys L., Van Erp P. et al. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late // Br. J. Dermatol. - 2004. - Vol. 150. - P. 852-859.</mixed-citation><mixed-citation xml:lang="en">Vissers W., Arndtz C., Muys L., Van Erp P. et al. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late // Br. J. Dermatol. - 2004. - Vol. 150. - P. 852-859.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wrone-Smith T., Johnson T., Nelson B., Boise L. et al. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo // Amer. J. Pathol. - 1995. - Vol. 146. - P.1079 -1088.</mixed-citation><mixed-citation xml:lang="en">Wrone-Smith T., Johnson T., Nelson B., Boise L. et al. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo // Amer. J. Pathol. - 1995. - Vol. 146. - P.1079 -1088.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Zhuang Sh, Demirs J., Kochevar I. p38 Mitogen-activated Protein Kinase Mediates Bid Cleavage, Mitochondrial Dysfunction, and Caspase-3 Activation during Apoptosis Induced by Singlet Oxygen but Not by Hydrogen Peroxide // J. Biol. Chem. - 2000. - Vol. 275. - P. 25939-25948.</mixed-citation><mixed-citation xml:lang="en">Zhuang Sh, Demirs J., Kochevar I. p38 Mitogen-activated Protein Kinase Mediates Bid Cleavage, Mitochondrial Dysfunction, and Caspase-3 Activation during Apoptosis Induced by Singlet Oxygen but Not by Hydrogen Peroxide // J. Biol. Chem. - 2000. - Vol. 275. - P. 25939-25948.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
